Loading…
Attending this event?
avatar for Stelios Tsinontides

Stelios Tsinontides

FDA, United States
Office Director, OPMA, OPQ, CDER
Dr. Stelios Tsinontides is the Office Director of the Office of Pharmaceutical Manufacturing Assessment (OPMA). OPMA evaluates facilities, process design, and control strategies to assess capabilities of manufacturers to produce quality pharmaceutical and biotechnology products at commercial scale and provides leadership and technical expertise to Agency components internal and external to the Office of Pharmaceutical Quality regarding manufacturing quality issues.

My Speakers Sessions

Tuesday, June 18
 

8:00am PDT

#212: Supporting Regulatory Convergence and Reliance Through a Pharmaceutical Quality Knowledge Management Capability Room 6F
 
Share Modal

Share this link via

Or copy link